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ABSTRACT
Citrus fruits are widely consumed and can offer various health benefits. One enzyme
found in grapefruits, Citrus paradisi flavonol specific 3-O-glucosyltransferase (CP3GT),
catalyzes the addition of glucose to one specific flavonoid class and at only one site. These
flavonoids are plant secondary metabolites that can be used in a variety of plant functions
including signaling and protection. The only class of flavonoids that CP3GT glucosylates is
flavonols, and this specificity is of interest to study for potential benefits in biotechnology and
enzyme modeling. In order to study this enzyme and its structure, a variety of mutants were
created using site-directed mutagenesis. One mutant, P297F, exhibited a loss of function. This
mutant was previously studied by inserting a thrombin cleavage site, extracting the plasmid
expressing the mutation and sequencing it. The gene sequence was previously verified to be in
frame and contain the needed thrombin cleavage site to remove tags used for protein purification
and identification. The plasmid was then linearized, and transformed into yeast. After this,
conditions for protein expression were tested over a 72-hour period. The protein was found to
have optimal expression at 50 hours with a constant temperature of 28 °C and methanol
concentration of 0.5 %. However, numerous protein expression experiments indicated very low
protein expression. For this reason, the P297F gene was amplified through colony PCR,
extracted and sent for sequencing to verify the transformation of the gene into yeast and identify
possible reasons for low protein production. Analysis of this sequencing data showed a single
nucleotide addition early in the tag sequence causing a frameshift after this location. Reanalysis
of the previous plasmid sequencing data showed this same mutation, indicating improper
conclusions were drawn. Efforts should be made to identify a plasmid without the mutation or
correct the frameshift mutation so that the tag sequence produces the correct amino acids.

1. INTRODUCTION
Enzymes are very valuable proteins to a variety of organisms. In plants, enzymes can
perform a variety of functions including glucosylation of various compounds and metabolites.
The enzyme of interest, Citrus paradisi flavonol specific 3-O-glucosyltransferase (CP3GT), adds
a glucose group onto only one subset of the flavonoid class of plant secondary metabolites (40).
The specificity of this enzyme makes it an ideal candidate for closer exploration to enhance the
knowledge of the structure-function relationship in glucosyltransferases.
Plants produce a variety of secondary metabolites which are compounds that can serve a
multitude of functions within the plant (39). One of the classes of plant secondary metabolites is
flavonoids. Flavonoids have a fifteen-carbon structure that contains two phenyl rings. The
functions of flavonoids within the plant encompass a broad range including coloration,
specifically flower pigmentation and UV patterning, antimicrobial and antipathogenic properties,
plant-insect interactions and sweet or bitter taste (14, 24, 36, 48). Flavonoids have also been
shown to play a role in plant reproduction, regulation and growth (3, 17, 43, 50).
The significant presence of flavonoids in plants arouses interest to study their effects on
other organisms, specifically mammals because the mammalian diet is often largely made up of
plants (34). Some common sources of flavonoids include parsley, blueberries, black, green and
oolong teas, and citrus fruits. Some studies have already shown positive health effects of
flavonoids including antioxidant, anticarcinogenic and estrogenic properties (20, 34, 49). These
have been found along with a decreased risk of neurodegenerative diseases and type II diabetes
(8, 15). In totality, flavonoids are a largely represented class of plant secondary metabolites that
can serve a broad variety of functions and benefits in both plants and other organisms.

The biosynthesis of flavonoids occurs through the phenylpropanoid metabolic pathway.
This pathway uses the amino acid phenylalanine to produce 4-coumaroyl-CoA which is then
used together with malonyl-CoA to produce chalcones (39). Chalcones are a class of flavonoids
that are considered the first true flavonoids and serve as a basis of many other classes of
flavonoids. These chalcones have two phenyl rings and can be isomerized to produce flavanones
containing three rings that can be modified to produce isoflavones, dihydroflavones and flavones
(11, 39). Dihydroflavones can undergo ring oxidation to produce flavonols and anthocyanins
(11, 39). Each of the classes, summarized in Figure 1, from chalcones to anthocyanins, can be
modified by substitutions to their ring system. These substitutions can take a variety of forms
including hydroxylation, methylation, glycosylation, prenylation. The most common
substitution to the flavonoid ring systems is the addition of sugars, more specifically
glucosylation (39).
By the metabolic pathway and subsequent modifications, there are many possible
flavonoids. Currently there have been over eight thousand unique flavonoids identified (39).
While this number is vast, individual plant species still tend to synthesize a specific set of
flavonoids.

Figure 1: Summary of some of the main classes of Flavonoids. (adapted from 33)
The biosynthesis of flavonoids is also greatly controlled by regulation and there are a
variety of factors to consider. These include biochemical regulation; reversible modification and
the number of enzymes present (11). Furthermore, biochemical regulation can be broken down
further into competition for substrate, substrate availability, affinities, inhibitors, activators and
pH effects. The same is for genetic factors which includes both developmental and
environmentally induced expression (39). There are also regulatory features within the plant to
consider including tissue-specific expression along with spatial and light regulation (39). While
it is known that the biosynthesis of flavonoids can be affected by the many factors listed earlier,
little is actually known about the regulation of the ring substitution reactions. These substitution
reactions are responsible for the accumulation of various specific flavonoids at different places in
different stages of plant development. Flavonoids have been shown to increase in concentration
in the rhizomes as certain tropical plants mature, likely due to their free radical scavenging

abilities (13). In citrus, the levels of flavonoids associated with bitter taste vary in concentration
in citrus tissues as the fruits mature (37). Therefore, development and regulation of biosynthesis
becomes apparent by the specific flavonoids in various tissues at different plant developmental
stages.
Enzymes that derive and modify flavonoids can be very specific. These enzymes can be
specific to substrate, position, or both (11). This specificity allows for the formation of the
numerous unique flavonoids mentioned above. Currently, there is no detailed information
known about the specifics of the regulation of enzymes involved in glucosylation of flavonols.
The few glucosyltransferase (GT) enzymes that have been cloned, named F3GTs, glucosylate a
variety of classes of flavonoids. The citrus GT of interest, named CP3GT, is specific to only
flavonols unlike some other F3GTs that have been studied and do not show this specificity
(e.g.12, 16, 22).
There are challenges in obtaining sufficient enzyme to study the structure/function
relationship from plants directly (31, 32). For this reason, molecular approaches were used to
obtain secondary product GT clones from a young Citrus paradisi (grapefruit) leaf cDNA library
(9, 40). Grapefruit plants have nearly a full spectrum of the main enzymes involved in flavonoid
biosynthesis (39). They also have a great diversity of GTs with some unique specificities. These
two things make Citrus paradisi an ideal model system to increase the diversity of knowledge on
GT enzymes.
When the amino acid sequence of the grapefruit GT of interest, CP3GT, was compared
with the sequences of known GTs there was between 30-60% identity. However, in a domain
called the PSPG (Plant Secondary Product Glucosyltransferase) box there was approximately
75% identity between the sequence of CP3GT and known GTs sequences (44). Currently

BLAST (add link) software predicts anything with a sequence like the PSPG box to be an F3GT
even if it has been characterized to have a different biochemical function from known F3GTs
(40). From this it can be concluded that functional identity cannot be determined from only
sequence analysis because there are currently not enough GT sequences published with a
biochemically established function (40). The structural characterization of CP3GT might also
help understand why in some cases there might be a low percentage identity between enzymes
with similar functions.
In order to begin studying and characterizing the structure and function of CP3GT, the
homology modeling programs PyMol Molecular Graphics (https://pymol.org/2/) and Python
Molecular Viewer (http://mgltools.scripps.edu/documentation/tutorial/python-molecular-viewer)
were used. This program takes amino acid sequences and predicts likely structures based on the
interactions of amino acids. While these programs are very advanced and provided a good
general idea of a structure they are still not yet developed enough to consistently predict
structures accurately. Like with the BLAST software mentioned earlier, more established
enzyme structure/function information would improve the predictions of these computer
homology modeling programs. If the crystal structure of a different biochemically functioning
enzyme, containing the PSPG box, could be established and compared to the computer
homology model, improvements to the software’s algorithms and computations could be made
based on the structural findings. This structure might serve as another guide for homology
modeling. In order to obtain homology modeling software that is accurate and robust, there must
be more than the few currently characterized enzymes contributing to the data used to shape
these models.

The glucosyltransferase enzyme of specific interest, CP3GT, was chosen to study
because of its biochemically characterized specificity to flavonols and its biochemically
characterized function that differs from what is currently predicted. As previously discussed,
this makes CP3GT an excellent enzyme to study to obtain more knowledge on the specificity of
enzymes and enhance computer homology modeling programs with more sequence and structure
data. It also contributes to enhanced knowledge of substrate and regiospecificity in GT enzymes
and increased insight into the complexity of structure-function relationships and interactions.
Studies of this enzyme would help understand what areas in the structure of the enzyme are key
in determining functionality and specificity. This can be explored on the basis of what specific
individual, or groups of amino acids are responsible for the interactions between structure and
function.
After successful cloning, recombinant expression, and biochemical characterization of
CP3GT over 30 mutants of this glucosyltransferase enzyme were created (39, 40). These mutants
were created by site-directed mutagenesis on sites of interest in the CP3GT sequence, and then
biochemically characterized. The analysis of CP3GT mutants adds dimension to the studies of
this specific GT along with providing more data to evaluate structure-function relationships (1,
10, 39, 46). The 30 mutants created and characterized, exhibited a variety of biochemical
functions, and predicted structure by homology modeling. Some of these characterized functions
and predicted models did not match up, further indicating the need for more sequence and
structural information to enhance homology modeling software (25, 46). One of the 30 mutants
created, named P297F, exhibited a loss of glucosylation function with only one amino acid
change (1).

This P297F mutant has the amino acid proline in the 297th position of the sequence
changed to the amino acid phenylalanine. With this single amino acid change, the CP3GT
mutant enzyme was unable to transfer a glucose group onto flavonols or any other class of
flavonoids. This makes the P297F mutant interesting to study because this site might have great
significance to the specificity of the CP3GT enzyme. The modeling software used to model this
mutant’s sequence predicts a blockage of the enzyme’s active site (1). Figure 2 shows the
predicted change in the structure of the loop (shown in pink) from the WT CP3GT to the P297F
which appears to block the mutant enzyme’s active site. This seems reasonable, but with
predictions from this same modeling software that do not align with biochemical function for the
wild type CP3GT and some mutants, this is not completely reliable (25, 46). For this reason, the
P297F mutant was studied in depth by expressing and purifying the recombinant protein to be
used for crystallization screens, where a crystal structure may reveal the correct enzyme
structure.

Figure 2: Model prediction of the structure of WT Cp3GT and P297F mutant. Note the change of
position of the pink loop near the active site (adapted from 1).
This thesis research was designed to test the hypothesis that the crystallization of the
P297F grapefruit GT mutant that rendered the enzyme inactive will be contained within the
conditions used for crystallization of other plant GTs. In order to begin crystallization screenings
of the P297F mutant a significant amount of recombinant protein must be expressed and purified.
After this the purified protein would be subjected to a matrix of crystallization conditions,
described in Figure 3, created from similar GTs that were successfully crystallized. Once
crystallization conditions are revised and quality crystals obtained, they may be subjected to xray diffraction. This would allow for the structure of the enzyme to be solved, and provide the
data to understand the structure-function relationships in this mutant enzyme compared with WT
CP3GT, while also providing data to strengthen modeling software.

Figure 3: Matrix of crystallization conditions for crystallized GTs most similar to Cp3GT.

2. MATERIALS AND METHODS
2.1 MATERIALS
All materials and sources along with reagents and recipes are provided in Appendix A.
2.2 PREVIOUS WORK WITH P297F AND THROMBIN CLEAVAGE SITE
Previous work with the P297F mutant of the CP3GT grapefruit enzyme used Site
Directed Mutagenesis to achieve the single amino acid change in the mutant (1). This mutant
recombinant P297F- pPICZa plasmid was transformed into an E. coli containing the mutant
gene, c-myc tag used for identification on western blot and 6x His tag used for protein

purification. This plasmid was also purified to a concentration of 77.45 ng/µL previously in
preparation for thrombin cleavage tag insertion.
The plasmid was also previously subjected to Site Directed Mutagenesis to insert a
thrombin cleavage site between the P297F gene and the c-myc and 6x His tags. The thrombin
cleavage site sequence codes for Leucine-Valine-Proline-Arginine-Glycine-Serine. Once
inserted, any recombinant protein treated with thrombin will cleave between the ArginineGlycine peptide bond, removing both the c-myc and 6xHis tags. Additionaly, the P297F pPICZa
plasmid in E. coli plasmid containing the P297F gene, thrombin cleavage site, c-myc tag, and 6X
His tag was extracted and sent for sequencing.
2.3 PLASMID EXTRACTION FOR TRANSFORMATION INTO YEAST
In preparation for extraction and transformation, P297F plasmid cell stocks were quickly
retrieved on ice from storage in -80 °C freezer, and a small piece of the stock was removed with
a sterile pipette tip and transferred to a new sterile microcentrifuge tube. The cell stock was then
immediately returned to the -80 °C freezer. The small quantity of stock removed was allowed to
thaw on ice in preparation for inoculation. LB agar plates were prepared and streaked with the
thawed cell stock, under a laminar flow hood. Once inoculated, this plate was placed in a 37 °C
incubator and allowed to grow for approximately 48 hours. Once easily distinguishable colonies
were formed, the plates were removed from the incubator and, under a laminar flow hood, a
single isolated colony was picked from the plate using a sterile pipette tip. This colony was then
used to inoculate 5 mL of LB liquid media in a sterile glass culture tube. This sample was then
placed into a 37 °C incubator shaker at an angle, to maximize aeration, and allowed to shake at
250 rpm until OD 600 of 1-2 was obtained, approximately 16 hours. Once sufficient growth
was established two independent cultures were used to extract the P297F plasmid following

Promega Wizard Plus Midiprep protocol (https://www.promega.com//media/files/resources/protocols/technical-bulletins/0/wizard-plus-sv-minipreps-dna-purificationsystem-protocol.pdf?la=en). The resulting extracted plasmids had concentrations of 191 and 171
ng/uL and were stored at 4 °C for future use.
2.4 SAC I DIGESTION OF PLASMID
Using the two extracted P297F plasmid samples from the mini prep described above, a
Sac I (Promega) restriction digest was performed to prepare for transformation into the yeast
genome. The restriction digest protocol for this Sac I (Promega) enzyme was followed and 10
ug of the digested product was electrophoresed on a 0.8% agarose gel at 100 V for
approximately 45 minutes to confirm digestion (https://www.promega.com/products/cloningand-dna-markers/restriction-enzymes/saci/?catNum=R6061#protocols).
2.5 DIGESTED DNA PURIFICATION
To purify the linearized extracted plasmid, 200 µL of previous restriction digest reaction
mixture was added to equal volume of cold phenol-chloroform in a sterile microcentrifuge tube.
This was vortexed on high for 30 seconds. The sample was then centrifuged at 13,000 rpm for 5
minutes. From the top layer 150 µL was removed and placed into a new sterile tube along with
1/10 volume of 3M sodium acetate. To this, 2.5 x total volume of ethanol was added and the
mixture was allowed to incubate for 1h at -80 °C. The sample was then centrifuged at 13,000
rpm for 20 minutes at 4 °C. The precipitated DNA formed a very small while pellet near the
bottom of the tube. The supernatant was decanted, and the tube containing the DNA pellet was
allowed to air dry for approximately 15 minutes. After drying, the DNA pellet was dissolved in
10 µL of sterile water and stored at 4 °C.

2.6 TRANSFORMATION INTO YEAST
A stock of X-33 Mut+ yeast cells was obtained and used to streak YDP media plates
using the same methods and streak to isolation technique as described previously. These plates
were placed in a 28 °C incubator and allowed to grow for approximately 48 hours. A single
isolated colony was picked using a sterile pipette tip and used to inoculate 5 mL of YPD media
with no zeocin added in a glass culture tube. This culture was placed into a 28 °C shaker at 250
rpm and at an angle and grown until an OD 600 of 1-2 was observed, approximately 16 hours.
A 250 µL aliquot of this culture was then used to inoculate 200 mL of fresh YPD media without
zeocin in a 1L baffled flask. This culture was placed into a 28 °C shaker at 250 rpm and grown
until an OD 600 of 1-2 was observed, approximately 16 hours. An aliquot of 50 mL of this
culture was placed into a centrifuge tube and centrifuged at 1500 g for 5 minutes. The
supernatant was decanted, and the cell pellet resuspended in 50 mL cold sterile dH2O,
centrifuged again, and the supernatant discarded. The washed cell pellet was then washed in the
same manner with 2mL cold 1M sorbitol. The cell pellet was then resuspended in
250 µL of 1M sorbitol.
In an electroporation cuvette on ice, 80 µL of the resuspended yeast cells were mixed
with 5 ng of the previously extracted, purified DNA. This mixture was allowed to incubated on
ice for 5 minutes, and then the cuvette was electrically pulsed according to the settings for the
yeast species Pichia pastoris in the protocol for the BioRad micro pulser (https://www.biorad.com/webroot/web/pdf/lsr/literature/4006174B.pdf). Immediately after pulsing the mixture
was added to 1mL of cold 1M sorbitol in a glass culture tube. The sample was incubated at 30°C
for 1 hour, then 1 mL of YPD media without zeocin added. The sample was then incubated in a
30 °C shaker at 200 rpm for an additional hour. Following this, 200uL of sample was placed

onto YPDS agar plates, without zeocin, and allowed to grow until colonies formed,
approximately 3 days.
Nine single colonies from the plates were picked using sterile pipette tips and used to
individually restreak onto a fresh YPD media plates with zeocin. This culture was allowed to
grow at 28 °C until individual colonies formed, approximately 48 hours. A colony from each of
the plates with growth was then picked using a sterile pipette tip and used to inoculate 5 mL
YPD media in a glass culture tube. This culture was placed at an angle into a 28 °C shaker at
250 rpm and grown until and OD 600 of 1-2 was observed, approximately 16 hours. From this
culture yeast transformant cell stocks were taken, combined with equal volume 50% glycerol and
stored at -80°C.
2.7 SCREENING OF YEAST CLONES
Following transformation, the transformant cell stocks were obtained and used to streak
onto YPD plates with zeocin, individual colonies were picked from these plates and then used to
restreak YPD plates with zeocin, using the same method as has been described before. From
these restreaked transformant plates, a single colony was picked using a sterile pipette tip and
used following the Emerald Amp protocol in a polymerase chain reaction
(http://www.takara.co.kr/file/manual/pdf/RR300A_DS.v1011Da.pdf). The PCR products were
then run on a 0.8% agarose gel at 100 V for approximately 45 minutes. Successful
transformation would be indicated by bands at ~1.7 kbp.
2.8 PROTEIN EXPRESSION
In order to obtain P297F protein sufficient for use in crystallization studies, the protein
expression must be optimized. To do this a time-course study of the P297F mutant protein
expression was conducted. The transformant cell stocks taken previously were used to streak

YPD plates in the same manner as described earlier. Once isolated colonies were obtained, the
protein expression protocol in the Pichia Manual was followed to culture cells in BMGY media,
and then induce protein expression in BMMY media
(http://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf). After the expression was
induced in the BMMY media culture by the addition of 0.5% methanol, the culture was allowed
shake at 250 rpm at 28 °C for 48 hours. Every 24 hours methanol was added to maintain the
0.5% final concentration in the culture. Approximately every 10 hours a 1.5 mL sample was
taken from the growing culture and placed into a microcentrifuge tube and centrifuged at 13,000
rpm for 2 minutes. The supernatant was discarded and the cell pellet was stored at -80 °C for
later analysis.
Upon visualization of the 48-hour time-course, it was repeated to see if protein
expression increased with extended time. For this reason, an extended 72-hour time-course was
also conducted in the same manner.
2.9 TIME-COURSE EXPRESSION ANALYSIS
Each sample obtained from the protein expression time courses was lysed following the
small sample protocol outlined in the Pichia Manual. Two 10% SDS Page gels were prepared
following the BioRad Mini Tetra cell manual (https://www.biorad.com/webroot/web/pdf/lsr/literature/10007296D.pdf), and 150-200 µg of protein (estimated
using Nanodrop) from the cell lysate for each time point was loaded into each well. A 5uL
volume of Thermofisher PageRuler protein ladder was also loaded for protein size comparison.
The SDS Page gels were run at 100 V for approximately 1.5 hours. Following this, one SDS
PAGE gels was stained with Coomassie blue and imaged. The other was subjected to western

blot at 100 V for 1 hour following the wet/tank electrophoresis protocol established in the
BioRad Mini Tetra Cell manual.
After the electrophoresis was finished, the western cassette was carefully removed from
the electrophoresis chamber and opened. The nitrocellulose membrane was removed, taking care
to touch only the very edge with the forceps, and placed inside a small dish containing 1X TBS.
This was allowed to shake and equilibrate at room temperature for approximately 5 minutes.
The membrane was then carefully removed and placed into a clean dish. A 50 mL volume of
blocking solution was prepared and poured over the membrane and the dish was sealed and
allowed to gently shake at room temperature for 2 hours. After blocking, the membrane was
washed thoroughly by allowing it to shake in a new dish with only 1X TBS for 5 minutes. The
membrane was then transferred to a new dish and 15 mL of mouse anti-c-myc primary antibody,
diluted 1:2500, was poured over the membrane. The dish was sealed and allowed to gently
shake overnight at 4 °C. The next morning the membrane was washed five times with 1X TBS,
placed in a new dish and 15 mL of goat anti-mouse-AP secondary antibody, diluted 1:10,000,
was poured over. This was allowed to gently shake at room temperature for 2 hours. The
membrane was then washed five times with 1X TBS and placed in a new dish after which AP
substrate was added (60 µL each of BCIP and NBT solutions were added to 15 mL of AP buffer)
and allowed to shake for approximately 5 minutes, or until visible purple bands appeared. After
the bands were clearly visible the membrane was quickly rinsed with dH2O to stop the
development process from progressing too far. The membrane was then gently blotted with filter
paper until dry. The membrane was then imaged and stored wrapped in foil to preserve and
prevent damage caused by light exposure.

2.10 YEAST TRANSFORMANT AMPLIFICATION FOR SEQUENCING
Following apparent low protein expression in the P297F yeast transformants, these
transformant samples were extracted and sent for sequencing analysis. Yeast transformant
stocks were obtained, and streaked onto YPD media plates, as previously described. From these
plates a single colony was picked and subjected to PCR following the Emerald Amp protocol
with the exception of the cycler settings which are described in Table 2 that were increased to
increase DNA yield (http://www.takara.co.kr/file/manual/pdf/RR300A_DS.v1011Da.pdf).
Table 2: PCR Thermocycler Settings for P297F Yeast Transformants Reactions
Phase
Time (s)
Cycles
Temperature (°C)
Initiation
95
300
1
Denaturation
94
25
45
Annealing
58
30
45
Elongation
72
300
45
Extension
72
420
1
The resulting products from the polymerase chain reaction were placed into a 0.8%
agarose gel along with 6uL Promega 1kbp DNA ladder and electrophoresed at 100 V for
approximately 45 minutes. Resulting band sizes were measured in comparison to the DNA
ladder, where a 1.7 kbp band was expected as the size of the P297F recombinant gene.
2.11 YEAST TRANSFORMANT EXTRACTION FOR SEQUENCING
A variety of bands, in the 1.5 – 2.5 kbp size range, on the electrophoresis gel from the
previous PCR products were extracted following the Genejet gel extraction kit protocol
(https://www.thermofisher.com/document-connect/documentconnect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFSAssets%2FLSG%2Fmanuals%2FMAN0012661_GeneJET_Gel_Extraction_UG.pdf&title=VXN
lciBHdWlkZTogR2VuZUpFVCBHZWwgRXh0cmFjdGlvbiBLaXQ=). The extracted DNA was
then stored at -20 °C.

2.12 SEQUENCING OF YEAST TRANSFORMANTS
A sample of the extracted yeast DNA resulting from the previous gel band extraction for
each yeast transformant was sent to the Molecular Biology Facility at the University of
Tennessee Knoxville for sequencing. Along with the plasmid, AOX and internal primer binding
to the inserted thrombin cleavage site, sequence in Table 3 below (obtained from Integrated
DNA Technologies) were sent for sequencing. The resulting sequence data was returned and the
program SnapGene was used to view and check for the correct mutation, thrombin cleavage site
insertion, C-myc tag and 6X His tag. The program was also used to analyze and determine if all
of these sequences were in frame.
Table 3: Internal Primer Complementing Thrombin Site Insert Sequences
5’ CCG CCA GCT TGG GCC CCT GGT GCC ACG CGG TTC CGA ACA AAA ACT CAT CTC 3’ - Forward
5” GAG ATG AGT TTT TGT TCG GAA CCG CGT GGC ACC AGG GGC CCA AGC TGG CGG 3’ - Reverse

3. RESULTS AND DISCUSSION
The results of the research conducted are described in the following section. Successful
transformation and optimization of protein expression would be visualized on agarose gels, and
western blots, respectively. Sufficient protein production would allow progression to
crystallization studies and analysis of the structure/function of the P297F mutant.
3.1 INSERTION OF THROMBIN CLEAVAGE SITE
The P297F mutant of CP3GT that was created previously by using Site Directed
Mutagenesis to change a proline to a phenylalanine in the 297th position of the gene sequence,
was a clone currently in an E. coli plasmid. This clone plasmid DNA was also previously
extracted at a concentration of 77.45 ng/µL in preparation for insertion of a thrombin cleavage

site. This cleavage site needed to be inserted between the CP3GT gene sequence and the
recombinant tags. These tags included a c-myc tag that binds to antibodies used in the
development of a western blot so that any P297F protein produced might be visualized. There
was also a 6xHis tag previously added that could be used to bind to a Cobalt affinity
chromatography column so that any recombinant P297F protein expressed might be purified, and
isolated from other proteins. The insertion of the thrombin cleavage site above these tags would
allow them to be cleaved by treatment with thrombin, following their use in protein identification
and purification.
The genetic sequence for the thrombin cleavage site to be inserted codes for the amino
acid sequence Leucine-Valine-Proline-Arginine-Glycine-Serine. Once inserted, any expressed
protein containing this sequence will be cleaved by thrombin at the Arginine-Glycine peptide
bond. The sequence is not repeated anywhere in the P297F mutant gene sequence, and
successful insertion of this thrombin cleavage site should allow for cleavage, and removal of the
c-myc and 6xHis tags from the protein.
This removal of tags after protein expression, identification and purification is significant
for future crystallization experiments. Such tags are not a part of the native protein sequence,
and could have effects on structure and function. The successful insertion of the thrombin
cleavage site would allow the native protein to be obtained and used in further crystallization and
structure-function studies. This eliminates the possibility of an any results due to effects of tags.
The previous analysis of the P297F plasmid sequencing data (Figure 1) stated that the thrombin
cleavage site was inserted successfully and the sequence was in-frame.

Figure 1: Previous analysis of P297F plasmid sequencing data showing thrombin cleavage site in
red brackets, c-myc tag in blue brackets, and 6xHis tag in green brackets.
(Figure courtesy Aaron Birchfield).
3.2 TRANSFORMATION INTO YEAST
An E. coli plasmid was used to amplify the recombinant P297F DNA prior to
transformation into yeast for expression. The species of yeast being transformed into was
Pichia pastoris. In order to prepare for transformation two independent samples of P297F in the
pPICZa E. coli plasmid were extracted, resulting in concentration of 191 and 171 ng/µL.
Before this gene could be transformed it to yeast it was linearized and purified to best
prepare it for acceptance by yeast cells. The results of the digest to linearize the plasmid were
run on a 0.8% agarose gel (Figure 2).
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Figure 2: Linearized plasmids from Sac I digestion. Lanes 1 and 3 contain undigested plasmid, 2
and 4 contain linearized plasmid, and 6 is a control WT CP3GT plasmid.
Figure 2 shows the successful digestion and linearization of both samples of the P297FpPICZa plasmids. Successfully linearized plasmids would not run as far on the gels as
supercoiled undigested plasmids. After linearization these samples were purified using phenolchloroform and then stored at -20 °C until transformation.
Now that the plasmid DNA was prepared, transformation into the yeast genome was
conducted. After the transformation procedure, the new transformants were grown and streaked
onto new plates. For this process nine colonies were chosen, and of these nine transformant
colonies, six showed growth under antibiotic selection (Figure 3).

Figure 3: Growth of P297F yeast transformants on YPD agar plates treated with zeocin. Colonies
formed on P297F transformant 2 plate shown with arrow.
This antibiotic selection was used to screen transformants because the P297F-pPICZa
plasmid linearized, and transformed into yeast contained a gene for resistance to the antibiotic
zeocin. Successful transformation would allow this resistance gene, contained on the same
plasmid as our P297F mutant gene, to be transferred into the yeast genome. By this, yeast media
could be supplemented with zeocin to screen for cells that had successfully incorporated the
recombinant P297F gene sequence.
The 6 colonies that showed growth were named PYT 1, 2, 4, 5, 6 and 9. Transformants
PYT1 and PYT6 showed the most growth on zeocin containing plates and were chosen to
continue experiments with. In order to more precisely verify the presence of our P297F gene in
these transformants, a colony PCR reaction was performed and the 0.8% agarose gel of the
products is shown below in Figure 4.

Lanes 1

2

3

4

5

6

7

Figure 4: Colony PCR products of PYT 1 (lanes 1-3), PYT 6 (lanes 4-6) and X33 yeast (lane 7)
with DNA ladder shown to scale of gel. Bands noted with arrow.
The P297F gene colony PCR product band is expected at 1.7 kbp size. From Figure 4, it
can be seen that PYT6 samples contained bands at this size. This confirmed the presence of the
P297F gene in these colonies.
3.3 PROTEIN EXPRESSION
With a successful P297F yeast transformant, experiments were designed to find the
optimized expression conditions for P297F protein production. Optimization of expression
conditions for this mutant protein would allow for collection and purification of the protein in
order to obtain a concentration high enough to conduct crystallization screens. In order to
optimize protein expression, the temperature, time and methanol concentration were tested.
Through protein expression experiments optimal protein expression of the P297F was found to
be at 28 ° C with a final methanol concentration of 0.5% and constant shaking at 250 rpm. With
these conditions a 48-hour time-course was conducted, and the time samples taken are shown on
the Coomassie gel and Western blot below in Figures 5 and 6, respectively.

Figure 5: Coomassie Stained SDS gel of 48-hour Time Course of P297F protein expression with
purified WT control. Each well loaded with 150 µg crude protein, and Thermofisher Protein
Ladder for size reference.

Figure 6: Western blot of 48 hour Time Course of P297F protein expression with WT control.
Each well loaded with 150 µg protein and Thermofisher Protein ladder for size reference.
The P297F protein of interest has a size of of 57 kDa. The band for the P297F protein is
hard to distinguish in the Coomassie stained gel in Figure 5. However, there was a visible

protein band at the anticipated size at 48 hours on the western blot in Figure 6. This band is clear
and appears in the same area as the WT control band indicating protein expression. However,
based on the faintness of this band, the experiment was repeated using an extended 72-hour time
course to test if protein expression increased with extended time. Results are shown on the
Coomassie gel and Western blot in Figures 7 and 8, respectively.

Figure 7: Coomassie Stained SDS gel of Time Course of P297F protein expression with WT
control. Each well loaded with 200 µg protein. The Thermofisher Protein Ladder was included
for size reference.

Figure 8: Western blot of Time Course of P297F protein expression with WT control. Each well
loaded with 200 µg protein and the Thermofisher Protein ladder was included for size reference.
From Figure 8 the darkest band is seen at 50 h, indicating this as the optimal time to
collect the culture for maximum protein expression. While these results on the Western blot are
clear enough to visualize, they still do not contain dark bands, that would indicate strong protein
expression. With further protein expression experiments these results were not able to be
reproduced consistently, or improved upon. Considering these inconsistencies and very low
protein expression, the original P297F yeast transformant stocks were reevaluated.
3.4 SEQUENCING OF YEAST TRANSFORMANTS
Based on the minimal success with P297F protein expression, the original 6 PYT
transformants were referenced for further analysis. It seemed plausible that some error may have
occurred with the transformation and incorporation of the plasmid DNA into the yeast genome.
To test this, multiple samples of the 6 original P297F transformants were subjected to an
increased colony PCR amplification, which was run on 0.8% agarose gels shown in Figure 9.

Figure 9: Colony PCR products from 6 P297F Yeast Transformants. 1.5 kbp noted with yellow
arrow and 2.5 kbp indicated with green arrow. Bands are marked with PYT #, and those bands
that were extracted and sent for sequencing with a black arrow.
From Figure 9, the scaled-up PCR amplification of P297F transformants show multiple
bands between the sizes of 2.5 and 1.5 kbp. According to the Pichia Manual the yeast
chromosome may show a band at 2.2 kbp, and we expect our band for the P297F gene to be at
1.7kbp. Due to the closeness of these values and bands on the gel, samples of both were
extracted, gel purified, and sent for sequencing.
The program SnapGene was used to analyze the sequencing results. For each excised
band sample sent there were 4 corresponding sequencing files from a AOX forward primer,
AOX reverse primer, forward thrombin internal primer, reverse thrombin internal primer. The
chromas file for each of these sequence files was evaluated, and any sequencing data that did not

correspond to a clear nucleotide reading was removed. These edited data from all four primers
for the sample extracted band sample were then pasted into a text document. These data
sequences were then used, along with the known WT CP3GT sequence, to create a consensus
sequence, shown in Figures 10-12 below, for each of the three bottom band samples sent for
sequencing. Analysis of all top and middle band samples, confirmed by BLAST software,
showed that they were parts of the yeast genome and not the P297F gene of interest.

Figure 10: Consensus sequence from sequencing data of excised band from transformant PYT1.
… indicates a sample size n=1. … indicates a sample size n=2. … indicates a sample size n=3.
… indicated a variation from WT CP3GT sequence. … indicates the P297F mutation. …
indicates a spaces sequence with sample size n=1. … indicates the thrombin cleavage site with
sample size n=1. … indicates the c-myc tag with sample size n=1. … indicates the 6xHis tag
with sample size n=1.

Figure 11: Consensus sequence from sequencing data of excised band from transformant PYT5.
… indicates a sample size n=1. … indicates a sample size n=2. … indicates a sample size n=3.
… indicated a variation from WT CP3GT sequence. … indicates the P297F mutation. …
indicates a spaces sequence with sample size n=1. … indicates the thrombin cleavage site with
sample size n=1. … indicates the c-myc tag with sample size n=1. … indicates the 6xHis tag
with sample size n=1.

Figure 12: Consensus sequence from sequencing data of excised band from transformant PYT9.
… indicates a sample size n=1. … indicates a sample size n=2. … indicates a sample size n=3.
… indicated a variation from WT CP3GT sequence. … indicates the P297F mutation. …
indicates a spaces sequence with sample size n=1. … indicates the thrombin cleavage site with
sample size n=1. … indicates the c-myc tag with sample size n=1. … indicates the 6xHis tag
with sample size n=1.

The consensus sequence can be used to verify the proper mutation, noted in dark blue,
indicating that the samples were indeed the correct P297F mutant. However, the consensus
sequence data for all three original transformant stock analyzed, PYT1, PYT5 and PYT9 all
show three unexpected variations from the P297F sequence. The first, highlighted in yellow in
Figures 10-12, is a change from a ‘C’ to a ‘G’ nucleotide. This mutation causes the formation of
the amino acid valine rather than isoleucine in the sequence. However, this is not of great
concern because these amino acids are conservative. The next variation, again highlighted in
yellow, is a change from a ‘T’ to a ‘C’ nucleotide. This mutation does not change the amino acid
formed, serine, and is thus not of great concern either.
However, the third unexpected variation from expected P297F sequence occurred in the
c-myc tag sequence and was the addition of a’ C’ nucleotide. This is of great concern, since
protein production cannot be verified by western blot or purified without proper production of
recombinant protein, and a single nucleotide insertion could alter the reading frame.
Once the consensus sequence was obtained it was translated into its corresponding amino
acid sequence using SnapGene software. This was done for the analyzed sequence containing
the C mutation and for the sequence if this mutation were to be removed. The results were
consistent across the 3 transformants analyzed and the sequences for PYT1 are shown in Figures
13 and 14.

Figure 13: Sequence and amino acid translation for PYT1 sequence containing C addition
mutation. Sites of P297F mutation and C addition noted with arrows. Note stop codon at amino
acid 495.

Figure 14: Sequence and amino acid translation for PYT1 sequencing data if C addition mutation
were to be removed. Site of P297F mutation and absence of C addition noted with arrows.
Thrombin cleavage site noted in orange, c-myc tag in blue, and 6x His tag in green.
From Figures 13 and 14 it can be seen that the correct mutation to change the 297th amino
acid from proline to phenylalanine was confirmed. However, it is clearly shown that the
presence of the additional ‘C’ nucleotide at the 485th amino acid position causes a frameshift in
the following protein sequence (Figure 13), so that only the first amino acid of the c-myc tag is
correct, and a stop codon is produced before what would have been the sequence for the 6x His
tag. If this additional C mutation were to be removed, Figure 14 shows that the entire sequence,
including the c-myc and 6xHis tag would be in frame and produce the proper protein sequence.

In order to determine if this addition mutation had occurred at transformation into yeast
or after, the previous plasmid sequencing files from after thrombin cleavage site insertion were
reexamined. Analysis of these previous files showed that the conclusion that all sequences were
in frame after the thrombin cleavage site insertion was false. Figure 15 shows the sequence of
the P297F plasmid, beginning at the 453rd amino acid, where the additional ‘C’ nucleotide is
clearly visible. This confirms that the mutation occurred previous to transformation into yeast,
and was not identified by previous research.

Figure 15: Plasmid P297F sequence beginning at 453rd amino acid, although denoted as 295th
amino acid. Note the presence of additional C mutation marked with arrow.
The failure to discover the existence of this mutation prior to the start of research likely
had significant implications. Considering that the research was conducted under assumptions of
in-frame sequences, this mistake was not detected until efforts to express and visualize the
protein production had been exhausted. The presence of this mutation, altering both the c-myc
tag and 6xHis tag, is likely responsible for the inability to strongly visualize protein production.
While sufficient protein may well have been produced, there would have been no way to
visualize this clearly due to the out of frame tags. Also, while the samples loaded for the
Coomassie stained gels were crude protein, it is possible that one of the bands at 57 kDa could
have been P297F protein produced, but not visualized on western blots because of altered tag
sequences. This is hard to tell because of the size and variety of protein bands in the crude

protein sample loaded, but seems plausible given the correct sequence and frame until near the
end where tags were located.
While the discovery of a mutation in the plasmid sequencing data had significant
implications, it does not exclude the data collected from this research. The P297F protein
sequence was correct and in frame until the very end in tag sequences. Thus, the conditions for
plasmid digestion and transformation likely still hold. Along with the conditions for protein
expression, where if very faint bands could be seen with a partial c-myc tag, likely strong bands
would be visualized at these conditions for a mutant with correct tag sequence. Such was the
case for WT CP3GT in parallel expression experiments. The transformant sequencing data also
provides information to compare with future sequencing data obtained to evaluate if variations
still remain. This research and sequencing analysis provide a cautionary example for proper
evaluation of sequencing data along with a strong foundation and directions for future research
conducted with the P297F mutant.
4. SUMMARY AND DIRECTIONS FOR FUTURE RESEARCH
The research conducted provided valuable insight and correction upon previous research
with P297F mutant. Previous evaluation of plasmid sequencing data failed to identify a
frameshift mutation that caused protein visualization to be obstructed in the research conducted.
However, this likely did not impair the discovery of optimized conditions for plasmid digestion,
transformation and protein expression. The P297F mutant has been evaluated further and is
closer to being ready to produce sufficient protein for use in crystallization studies.
Future research should consult original P297F recombinant plasmids and have them
sequenced. Following the DNA sequencing this plasmid sequencing data should be evaluated
thoroughly using methods like those described in the sequencing analysis of this research, not

like those of previous research. If any recombinant plasmids show no additional C mutation like
the one described in this research, and no other impactful mutation, these should be chosen kept
with proper labeling integrity. Should no recombinant plasmids be found without any impactful
mutations, efforts to remove mutations or create new recombinant P297F mutant plasmids
should be taken.
Once a P297F plasmid with thrombin site and tags in frame is observed, further
transformation experiments should be conducted. Digestion of plasmid and transformation into
yeast should be conducted using the same protocol as described in this research. Following this,
protein expression should be conducted following the protocol described in the research and be
conducted at 28° C and 0.5% methanol concentration for approximately 50 hours. Based on the
results from this research, these conditions should likely give maximum protein production given
that the tags are in frame for proper visualization.
After protein production the protein should be run through a Cobalt affinity
chromatography column to remove the other proteins produced that are not of interest. The
purified protein should then be subjected to thrombin digestion to cleave tags and run through a
gel filtration column to remove the thrombin and cleaved tags. The remaining native P297F
protein should be purified to at least 95% purity and concentrated so that it can be used in
crystallization screens.
Crystallization screens should begin using the matrix of conditions used to crystallize the
most similar GTs, described previously in Figure 3. If no crystals should be observed, the matrix
of conditions should be varied until crystals are observed. Once crystals are observed, a
narrower matrix of conditions should be created around the conditions where the crystal
formation was observed. This should be repeated until crystals of high quality are obtained.

Following this the crystals should be subjected to x-ray crystallography so that the structure of
the P297F mutant can be solved.

APPENDIX A – MATERIALS
10X SDS-Page buffer (1000 mL)
30.28 g Tris Base
144.14 g Glycine
10 g SDS
Dissolve in 1000 mL dH2O
Store at room temperature
1X SDS-Page buffer (1000 mL)
100 mL 10X SDS-Page buffer
Add to 900 mL dH2O
Store at room temperature
4X SDS-Page Loading Dye (10 mL)
2.4 mL of 1 M Tris (pH 6.8)
0.8 g SDS
4 mL 100% glycerol
4 mg bromophenol blue
3.1 mL dH2O
Store at room temperature
Add 50 µL BME per mL loading dye immediately before use
10X Western buffer (1000 mL)
30.28 g Tris Base
144.14 g Glycine
Dissolve in 1000 mL dH2O
Store at room temperature
1X Western buffer (1000 mL)
100 mL 10X Western buffer
200 mL Methanol
Add to 700 mL dH2O
Store at 4 C
Blocking Solution (50 mL)
2.5 g non-fat milk powder
Dissolve in 50 mL 1X TBS
Add 50 µL 20% sodium azide
20% Sodium Azide (1 mL)
0.1 g sodium azide
Dissolve in 1 mL dH2O
Store at 4 C

20X TBS (1000 mL)
160 g NaCl
4 g KCl
60 g Tris Base
Dissolve in 700 mL dH2O
Adjust to pH 7.4 with 6N HCL
Make up volume to 1000 mL with dH2O
Store at room temperature
1X TBS (1000 mL)
50 mL 20X TBS
Add to 950 mL dH2O
Store at room temp
Primary Antibody (1:2500)
6 µL of anti-C-myc monoclonal antibody from mouse
Add to 15 mL 1X TBS
Secondary Antibody (1:10,000)
1.5 µL of anti-mouse IgG from goat
Add to 15 mL 1X TBS
Alkaline Phosphate buffer (500 mL)
2.925 g NaCl
507.5 mg MgC12.6H2O
50 mL of 1M CHES buffer
Dissolve in 275 mL dH2O
Adjust pH to 9.5
Make up volume to 500 mL with dH2O
Store at room temperature
NBT solution (1 mL)
83 mg Nitro blue tetrazolium
Dissolve in 700 µL N, N-dimethylformamide
Add 300 µL of dH2O
Store at -20 C
BCIP solution (1 mL)
42 mg BCIP
Dissolve in 1 mL N, N-dimethylformamide
Store at -20 C

0.8% Agarose gel (50ml)
0.4 g Agarose
Dissolve in 50 ml 1X TAE buffer
Microwave 60 seconds, or until agarose dissolves
Allow to cool for 3 minutes
Add 2.5 µL of 10mg/mL ethidium bromide
50X TAE Buffer (1000 mL)
242 g Tris base
57.1 mL glacial acetic acid
100 mL 0.5 M EDTA (pH 8.0)
Dissolve in 700 mL dH2O
Make up volume to 1000 mL
Store at room temperature
1X TAE (1000 mL)
20 mL 50X TAE
Add to 980 mL dH2O
Store at room temperature
Zeocin (100mg/mL) (1 mL)
0.1 g Zeocin
Dissolve in 1 mL dH2O
Filter sterilize
Store at -20 C
Low salt Luria broth (LB) liquid media (200 mL)
1 g yeast extract
2 g tryptone
2 g sodium chloride
Dissolve in 180 mL dH2O
Adjust to pH 7.5 with 1M NaOH
Make up volume to 200 mL with dH2O
Autoclave 20 minutes
Before use add 50 µL of Zeocin (100mg/mL)
Store at 4 C

Low salt Luria broth agar plates (200 mL)
1 g yeast extract
2 g tryptone
2 g sodium chloride
Dissolve in 150 mL dH2O
Adjust to pH 7.5 with 1M NaOH
Add 3 g agar
Make up volume to 200 mL with dH2O
Autoclave 20 minutes
Once cooled for approximately 10 minutes, add 50 uL Zeocin (100mg/mL)
Pour approximately 25 mL into plates
Allow to solidify, approximately 10 minutes
Store at 4 C
3M sodium Acetate (100 mL)
40.8 g sodium acetate
Dissolve in 70 mL dH2O
Adjust to pH 5.2 with glacial acetic acid
Bring volume up to 100 mL with dH2O
Store at room temperature
YPD liquid media (200 mL)
2 g yeast extract
4 g peptone
Dissolve in 180 mL dH2O
Adjust to pH 6.5
Autoclave 20 minutes
Cool for approximately 15 minutes
Add 20 mL 20% dextrose
Add 200 µL Zeocin (100mg/mL)
Store at 4 C
YPD agar plat (200 mL)
2 g yeast extract
4 g peptone
Dissolve in 180 mL dH2O
Adjust to pH 6.5
Add 4 g agar
Autoclave 20 minutes
Cool for approximately 15 minutes
Add 20 mL 20% dextrose
Add 200 uL Zeocin (100mg/mL)
Pour approximately 25 mL into plates and let set for approximately 10 minutes
Store at 4 C

YPDS liquid media (200 mL)
2 g yeast extract
4 g peptone
36.44 g sorbitol
Dissolve in 180 mL dH2O
Adjust to pH 6.5
Autoclave 20 minutes
Cool for approximately 15 minutes
Add 20 mL 20% dextrose
Add 200 µL Zeocin (100mg/mL)
Store at 4 C
YPDS agar plate (200 mL)
2 g yeast extract
4 g peptone
36.44 g sorbitol
Dissolve in 180 mL dH2O
Adjust to pH 6.5
Add 4 g agar
Autoclave 20 minutes
Cool for approximately 15 minutes
Add 20 mL 20% dextrose
Add 200 µL Zeocin (100mg/mL)
Pour approximately 25 mL into plates and let set for approximately 10 minutes
Store at 4 C
20% Dextrose (100 mL)
20 g dextrose
Dissolve in 80 mL dH2O
Make up volume to 100 mL with dH2O
Autoclave 20 minutes
Store at room temperature

AOX, Thrombin Cleavage and Internal Primers were designed and purchased
through Integrated DNA technologies.
Agilent Site Directed Mutagenesis Kit – Catalog # 200523
Promega 1kbp DNA Ladder – Catalog # G5711
Wizard Plus Miniprep kit – Catalog # A1330
Wizard Plus Midiprep kit – Catalog # A7640
Promega Sac I Digestion enzyme – Catalog # R6061
Emerald Amp Mastermix – Catalog # RR320B
Thermofisher PageRuler Protein Ladder – Catalog # 26616
GeneJet DNA Gel Extraction Kit – Catalog # K0691
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